ArticleGynecologic oncology reports2026

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer.

Jordyn Silverstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.